Human lung organoids with a built-in immune system could transform respiratory disease research (opens in a new tab)

medicalxpress.com · 2026-10-07

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Human lung organoids with a built-in immune system could transform respiratory disease research

medicalxpress.com · 2026-10-07

The story’s checkable claims.

Read the original story

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence

The source study

Human lung organoid modelling of tissue-resident antiviral T cell responses

Nature · 2026

Open source record

Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Reading mode

Scan verdicts. Open evidence only when needed.

Claim 1 of 4Not checkedResearchers at Stanford University School of Medicine built human lung organoids from intact distal lung tissue that retain key immune cell populations long term.View evidenceHide evidence

As statedmore than 220 patient volunteers; up to several months

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 4Not checkedWhen the organoids were infected with SARS-CoV-2, they mounted not only generic inflammatory reactions but also adaptive virus-specific T-cell responses.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 4Not checkedPrestimulating the organoids with fragments of the virus before infection, as a kind of vaccination, made future SARS-CoV-2 infections weaker.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 4Not checkedThe authors suggest the platform could support research on local vaccination strategies and on tissue-resident immune responses in other pulmonary diseases such as COPD, asthma, and bacterial infections.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer